Therapeutic Potential of Silver Nanoparticles (AgNPs) as an Antimycobacterial Agent: A Comprehensive Review
Nilakshi Barua, Alak Kumar Buragohain, Serena Riela · 2024
Read Therapeutic Potential of Silver Nanoparticles (AgNPs) as an Antimycobacterial Agent: A Comprehensive Review by Nilakshi Barua, Alak Kumar Buragohain, Serena Riela (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11591479.txt.
Description
Nilakshi Barua and A K Buragohain review, in a 2024 paper, whether silver nanoparticles could help treat tuberculosis. The lung disease remains a global health threat, in part because some strains now resist the standard drugs. New drugs are in trials, but the bacterium's complex cell wall and its life inside host cells slow that work.
Silver nanoparticles kill a wide range of microbes, and tests show they can act against the tuberculosis bacterium, including drug-resistant strains. Combined with standard drugs, they may raise the drugs' effect and shorten treatment. The review weighs these gains against open problems. Delivering the particles to the right site is hard, their killing power inside host cells varies, and harm to the body is a concern. The authors map where the field stands and what must be fixed, such as targeted delivery and safe dosing.
Catalog record
| CREATOR | Nilakshi Barua, Alak Kumar Buragohain, Serena Riela |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 59 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |